Investigating the Efficacy of a Dentifrice in Providing Long Term Relief From Dentinal Hypersensitivity

PHASE3CompletedINTERVENTIONAL

Enrollment

119

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions

Dentine Hypersensitivity

Interventions

DRUG

Stannous fluoride

Test dentifrice containing 0.454% SnF

DRUG

Sodium monofluorophosphate

Control dentifrice containing 0.76% w/w Sodium Monofluorophosphate \[1000 parts per million (ppm) fluoride\]

Trial Locations (1)

Salus Research, Inc., Fort Wayne